News

ReGelTec Inc., a company developing a percutaneous hydrogel implant for the treatment of chronic low back pain caused by degenerative disc disease, announced it has treated the first patient in its HYDRAFIL-D FDA investigational device

Expanding Innovations? (EI), a rapidly growing spine company specializing in NON-SCREW-based Expandable Technology, today announced U.S. FDA 510(k) clearance for its N-GAGE? Lumbar Plate System?the company's

Adona Medical, a Shifamed portfolio company that is developing one of the world's first combined therapeutic/diagnostic cardiovascular implants, announced today the completion of enrollment in the ATHENS-HF first-in-human study.

Erlanger, a nationally-acclaimed, multi-hospital health system, announced today a strategic partnership with Qventus, the industry?s premier provider of AI-based care operations automation software

MicroTransponder?, Inc., a commercial-stage medical technology company and developer of the breakthrough Vivistim? PairedVNS? System for chronic stroke recovery, today announced that Connecticut created legislation

AdventHealth Tampa is now the first hospital in the Tampa Bay region to successfully perform a transabdominal colorectal surgery using the da Vinci SP (single port) robot, taking the next step forward in providing

Stanford Health Care, one of the nation's leading academic medical centers, tapped Kivo Health as part of a collaboration to advance AI-powered virtual pulmonary rehabilitation and care for patients with Chronic Obstructive Pulmonary Disease (COPD).

Stanford Health Care, one of the nation's leading academic medical centers, tapped Kivo Health as part of a collaboration to advance AI-powered virtual pulmonary rehabilitation and care for patients with Chronic Obstructive Pulmonary Disease (COPD).

Stanford Health Care, one of the nation's leading academic medical centers, tapped Kivo Health as part of a collaboration to advance AI-powered virtual pulmonary rehabilitation and care for patients with Chronic Obstructive Pulmonary Disease (COPD).

Neurent Medical, a leader in pioneering non-surgical solutions for chronic sinonasal inflammatory diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the company's